NCT03393923

Brief Summary

Ostearthritis is a great source of pain. In symptomatic hip the pain can lead the major disability and poor quality of life. Understand the musculoskeletal factores can lead to a better clinical management. The muscle strenghening of posterolateral complexo of hip is a important consideration. General Objective: Perform a Kinetic analysis 2D using na anterior wedge. Specific objective: Analyze the influence of posterolateral hip complex. Controlled clinical trial, composed by 30 individuals with and without osteoarthritis of hip e will be used a tools; Analogic Visual Scale, manual dynamometry to analyze force and kinetic analyze of gait through of Myovídeo analysis software.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 10, 2017

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2018

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

January 3, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 9, 2018

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2018

Completed
Last Updated

February 26, 2019

Status Verified

January 1, 2017

Enrollment Period

6 months

First QC Date

January 3, 2018

Last Update Submit

February 25, 2019

Conditions

Gait, Frontal

Outcome Measures

Primary Outcomes (1)

  • Inproved performance of the gluteus maximus

    Extent moment will be assessed by gait analysis

    24 hours

Study Arms (2)

Control Group

NO INTERVENTION

Patient will undergo gait analysis

Experimental group

EXPERIMENTAL

Patient will undergo gait analysis with use of anterior wedge

Other: Application of the anterior wedge

Interventions

Application of the anterior wedgeOTHER

Application of anterior wedge in tennis

Experimental group

Eligibility Criteria

Age50 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Sedentary individuals
  • Both genders
  • Age equal to or greather than 50 years
  • Diagnosis of osteoarthritis level II and III

You may not qualify if:

  • fractures
  • Neuromuscular diseases
  • Other diseases of hip

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Flávia Nakatake

São Paulo, 03918000, Brazil

Location

MeSH Terms

Conditions

Gait Disorders, Neurologic

Condition Hierarchy (Ancestors)

Neurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Claudio Cazarini Júnior

Study Record Dates

First Submitted

January 3, 2018

First Posted

January 9, 2018

Study Start

July 10, 2017

Primary Completion

January 1, 2018

Study Completion

December 10, 2018

Last Updated

February 26, 2019

Record last verified: 2017-01

Locations

BR(1)